Frequent detection of cell-associated HIV-1 RNA in patients with plasma viral load <50 copies/ml

被引:8
作者
Kupfer, Bernd
Matz, Bertfried
Daeumer, Martin P.
Roden, Fabienne
Rockstroh, Juergen K.
Qurishi, Nazifa
Spengler, Ulrich
Kaiser, Rolf [1 ]
机构
[1] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, D-5300 Bonn, Germany
[2] Univ Cologne, Inst Virol, Cologne, Germany
[3] Univ Bonn, Dept Internal Med 1, D-5300 Bonn, Germany
关键词
CD4(+) T lymphocytes; PBMC; intracellular; transcription; residual replication; sequence analysis;
D O I
10.1002/jmv.20993
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Despite prolonged undetectable plasma viral load some HIV-1 infected patients have been reported to develop resistance-associated mutations leading to treatment failure. The mechanisms for this phenomenon and the point of origin for residual viral evolution are still not elucidated. In order to quantify cell-associated HIV-1 RNA in patients with different levels of plasma viremia paired cell-associated HIV-1 RNA loads and plasma viral loads were determined. Weak inverse correlation between these parameters and the amounts of CD4(+) T cells was observed, whereas there was no correlation between viral loads and CD8(+) T cells or CD14(+) monocytes, respectively. In a subset of patients, cell-associated and plasma HIV-1 envV3 sequences were analyzed. Plasma viral load and the amount of cell-associated HIV-RNA correlated strongly. However, in 62.3% of patients with undetectable plasma viral load cell-associated HIV-RNA could be detected. Analyses of HIV-RNA in plasma and blood cells showed identical sequences in 4/19 patients, whereas the majority of patients had differing HIV-1 RNA sequences in plasma and cells, respectively. In summary, this study shows that residual viral replication in peripheral blood still occurs in the majority of patients with undetectable plasma viral load. Since these replication events could lead to ongoing viral evolution it should be considered to optimize antiretroviral therapy in order to minimize the development of drug resistance.
引用
收藏
页码:1440 / 1445
页数:6
相关论文
共 28 条
[1]   Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy [J].
Aleman, S ;
Söderbärg, K ;
Visco-Comandini, U ;
Sitbon, G ;
Sönnerborg, A .
AIDS, 2002, 16 (07) :1039-1044
[2]   Residual human immunodeficiency virus type 1 viremia in some patients on Antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells [J].
Bailey, JR ;
Sedaghat, AR ;
Kieffer, T ;
Brennan, T ;
Lee, PK ;
Wind-Rotolo, M ;
Haggerty, CM ;
Kamireddi, AR ;
Liu, Y ;
Lee, J ;
Persaud, D ;
Gallant, JE ;
Cofrancesco, J ;
Quinn, TC ;
Wilke, CO ;
Ray, SC ;
Siliciano, JD ;
Nettles, RE ;
Siliciano, RF .
JOURNAL OF VIROLOGY, 2006, 80 (13) :6441-6457
[3]   CONCURRENT EVOLUTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PATIENTS INFECTED FROM THE SAME SOURCE - RATE OF SEQUENCE CHANGE AND LOW-FREQUENCY OF INACTIVATING MUTATIONS [J].
BALFE, P ;
SIMMONDS, P ;
LUDLAM, CA ;
BISHOP, JO ;
BROWN, AJL .
JOURNAL OF VIROLOGY, 1990, 64 (12) :6221-6233
[4]   The macrophage response to HIV-1: Intracellular control of X4 virus replication accompanied by activation of chemokine and cytokine synthesis [J].
Chowdhury, IH ;
Bentsman, G ;
Choe, W ;
Potash, MJ ;
Volsky, DJ .
JOURNAL OF NEUROVIROLOGY, 2002, 8 (06) :599-610
[5]   Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].
Chun, TW ;
Carruth, L ;
Finzi, D ;
Shen, XF ;
DiGiuseppe, JA ;
Taylor, H ;
Hermankova, M ;
Chadwick, K ;
Margolick, J ;
Quinn, TC ;
Kuo, YH ;
Brookmeyer, R ;
Zeiger, MA ;
BarditchCrovo, P ;
Siliciano, RF .
NATURE, 1997, 387 (6629) :183-188
[6]   Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART [J].
Delobel, P ;
Sandres-Sauné, K ;
Cazabat, M ;
L'Faqihi, FE ;
Aquilina, C ;
Obadia, M ;
Pasquier, C ;
Marchou, B ;
Massip, P ;
Izopet, J .
AIDS, 2005, 19 (16) :1739-1750
[7]   In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months [J].
Di Mascio, M ;
Dornadula, G ;
Zhang, H ;
Sullivan, J ;
Xu, Y ;
Kulkosky, J ;
Pomerantz, RJ ;
Perelson, AS .
JOURNAL OF VIROLOGY, 2003, 77 (03) :2271-2275
[8]   MASSIVE COVERT INFECTION OF HELPER T-LYMPHOCYTES AND MACROPHAGES BY HIV DURING THE INCUBATION PERIOD OF AIDS [J].
EMBRETSON, J ;
ZUPANCIC, M ;
RIBAS, JL ;
BURKE, A ;
RACZ, P ;
TENNERRACZ, K ;
HAASE, AT .
NATURE, 1993, 362 (6418) :359-362
[9]   Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J].
Finzi, D ;
Blankson, J ;
Siliciano, JD ;
Margolick, JB ;
Chadwick, K ;
Pierson, T ;
Smith, K ;
Lisziewicz, J ;
Lori, F ;
Flexner, C ;
Quinn, TC ;
Chaisson, RE ;
Rosenberg, E ;
Walker, B ;
Gange, S ;
Gallant, J ;
Siliciano, RF .
NATURE MEDICINE, 1999, 5 (05) :512-517
[10]   Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy [J].
Finzi, D ;
Hermankova, M ;
Pierson, T ;
Carruth, LM ;
Buck, C ;
Chaisson, RE ;
Quinn, TC ;
Chadwick, K ;
Margolick, J ;
Brookmeyer, R ;
Gallant, J ;
Markowitz, M ;
Ho, DD ;
Richman, DD ;
Siliciano, RF .
SCIENCE, 1997, 278 (5341) :1295-1300